The trademark LUZSANA BIOTECHNOLOGY was filed by HengRui, USA Ltd., a U.S. corporation (the "Applicant"). The application was published for oppositions on August 1, 2022, and received one opposition filed on October 25, 2022 by Laboratorios HARTMANN S.A. on Likelihood of confusion. the opponent was represented by STUMPF PATENTANWÄLTE PARTGMBB and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued October 25, 2022
The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).